Greensboro, NC, United States of America

William Kenneth Banner

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Transtech Pharma, Inc., Vtv Therapeutics LLC, High Point Pharmaceuticals, LLC. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Kenneth Banner. Retrieved from https://idiyas.com/inventor/william-kenneth-banner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 85.7

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 8.8

ph-index = 3

Forward Citations = 21(Granted Patents)

Company Filing History:

3 out of 49

Transtech Pharma, Inc.

High Point Pharmaceuticals, LLC

patents

Years Active: 2013-2024

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11970457 - Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine (2024-04-30),

2. 11524942 - Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine (2022-12-13),

3. 10364233 - Piperidine derivative and methods of use thereof (2019-07-30),

4. 9045461 - Phenyl-heteroaryl derivatives and methods of use thereof (2015-06-02),

5. 8741900 - Phenyl-heteroaryl derivatives and methods of use thereof (2014-06-03),

6. 8450354 - Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as β-secretase inhibitors (2013-05-28),

7. 8431575 - Phenyl-heteroaryl derivatives and methods of use thereof (2013-04-30),

Title: William Kenneth Banner: A Legacy of Innovation in Technology

Introduction:

William Kenneth Banner, a renowned inventor based in Greensboro, NC, has left an indelible mark on the world of technology through his passion for innovation and unwavering commitment to excellence. His visionary approach continues to inspire future generations of inventors.

Latest Patents:

Banner's latest patents revolve around metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine. These metabolites, with the potential to act as RAGE antagonists, hold significance in assays for measuring the presence or quantity of metabolites derived from the parent compound in a given sample.

Career Highlights:

With an impressive portfolio of 7 patents to his name, Banner's expertise shines through in the intricacies of his inventions. Having contributed significantly to companies such as Transtech Pharma, Inc. and VTV Therapeutics LLC, his work has been instrumental in pushing the boundaries of technological advancement.

Collaborations:

Throughout his career, Banner has collaborated with esteemed professionals, including Robert Carl Andrews and Anitha Hari. Together, they have brought forth innovative solutions and breakthrough inventions, further cementing Banner's reputation as a pioneer in his field.

Conclusion:

William Kenneth Banner's remarkable journey as an inventor underscores his invaluable contributions to the realm of technology. His legacy serves as a beacon of inspiration for aspiring inventors, highlighting the transformative power of innovation and the boundless possibilities it holds for shaping the future.

Profile summary based on public USPTO records.